Rob Dillard

DocwireNews

Screening for atrial fibrillation (<a href="https://www.docwirenews.com/condition-center/atrial-fibrillation/carbohydrate-antigen-125-is-an-independent-predictor-of-af-recurrence-following-radiofrequency-catheter-ablation/">AFib</a>) in older adults (75-76-year-olds) may reduce the risk of stroke, severe bleeding and death, according to a study published in The Lancet.&ldquo;There has never really been a study that examines if it would be beneficial to screen for atrial fibrillation, which is why we wanted to investigate it,&rdquo; says Dr. Emma Svennberg, cardiologist at the Karolinska University Hospital, Huddinge, and researcher at the Department of Medicine, Huddinge, Karolinska Institutet via a <a href="https://www.eurekalert.org/news-releases/926645">press release</a> about the study.The study comprised of almost 28,000 individuals, all all 75- and 76-year-olds in the two Swedish regions of Halland and Stockholm. The population of interest were all randomized to either screening (n=13,979) or to a control group (n=13,996), who received standard care. The screening group all completed a health questionnaire and underwent electrocardiogram.Patients without AFib got to take home the ECG device and were asked to record their heart rhythm twice daily for two weeks. Any patients with a detected&nbsp; irregular heart rhythms, the participants were referred to a cardiologist for a standardized work-up and treatment. The population were followed up for at least five years.According to the results, the detection of AFib was higher in the screening group, and the screening group also had a slightly lower incidence of death, stroke and severe bleeding than the control group. &ldquo;In total, 31.9 percent of those in the screening group experienced a negative event compared to 33 percent in the control group,&rdquo; says Johan Engdahl, adjunct lecturer at the Department of Clinical Sciences, Danderyds Hospital, at Karolinska Institutet. &ldquo;Now, that may sound like a small difference, but you must bear in mind that only about half of those invited to screening participated and it&rsquo;s possible we would have seen a more pronounced difference had more people turned up for screening. Those who participated in the screening had significantly fewer negative events.&rdquo;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Screening for atrial fibrillation could reduce risk of stroke <a href="https://t.co/cY1LI0kNLV">https://t.co/cY1LI0kNLV</a>
&mdash; Cision News (@CisionNews) <a href="https://twitter.com/CisionNews/status/1432009277384790017?ref_src=twsrc%5Etfw">August 29, 2021</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&nbsp;Moreover, the results of a financial analysis yielded promising results, showing that the screening is cost-effective. &ldquo;The results mean that decision-makers will be in a better position about deciding whether to move forward with recommending screening for atrial fibrillation in Sweden as well as internationally,&rdquo; Dr. Svennberg says. &ldquo;In future studies, we need to examine what it looks like in other health care settings in other countries and in different ethnical groups, and also if other age groups could benefit from screening.&rdquo;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Screening for atrial fibrillation could reduce risk of stroke &ndash; <a href="https://t.co/WbduUqX0Un">https://t.co/WbduUqX0Un</a>
&mdash; Golden Casino News (@GoldenCasinoNws) <a href="https://twitter.com/GoldenCasinoNws/status/1432011297504350212?ref_src=twsrc%5Etfw">August 29, 2021</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Screening for atrial fibrillation in the elderly could reduce the risk of <a href="https://twitter.com/hashtag/stroke?src=hash&amp;ref_src=twsrc%5Etfw">#stroke</a>, severe bleeding and death, according to a study in <a href="https://twitter.com/TheLancet?ref_src=twsrc%5Etfw">@TheLancet</a> by KI researchers <a href="https://twitter.com/EmmaSvennberg?ref_src=twsrc%5Etfw">@EmmaSvennberg</a>, <a href="https://twitter.com/JohanEngdahl2?ref_src=twsrc%5Etfw">@JohanEngdahl2</a> and others. <a href="https://twitter.com/hashtag/ESCCongress?src=hash&amp;ref_src=twsrc%5Etfw">#ESCCongress</a> <a href="https://twitter.com/hashtag/atrialfibrillation?src=hash&amp;ref_src=twsrc%5Etfw">#atrialfibrillation</a> <a href="https://twitter.com/hashtag/CardioTwitter?src=hash&amp;ref_src=twsrc%5Etfw">#CardioTwitter</a> <a href="https://t.co/AFVUT9MUnu">https://t.co/AFVUT9MUnu</a> <a href="https://t.co/2LIkWlnA13">pic.twitter.com/2LIkWlnA13</a>
&mdash; Karolinska Institutet (@karolinskainst) <a href="https://twitter.com/karolinskainst/status/1432044933054091273?ref_src=twsrc%5Etfw">August 29, 2021</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&nbsp;&nbsp;

Roger Rodby, MD

Joel M. Topf, MD, FACP

Seldin Award Winner Advocates Online Education

NKF Spring Clinical Meetings 2025

Hatem Soliman, MD

The Future of Dendritic Cell Vaccines in HER2+ Breast Cancer: Toward De-Escalation of Chemotherapy

HER2 Breast Cancer

Jordana Jampel

Mechanism of Positive Association Between Parkinson’s Disease and Melanoma Revealed in New Research

Melanoma

Latest News

Screening for AFib Could Reduce Stroke Risk in Elderly Adults

Atrial Fibrillation

Screening for atrial fibrillation (AFib) in older adults (75-76-year-olds) may reduce the risk of stroke, severe bleeding and death, according to a study published in The ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe